1. Home
  2. VNRX vs DHAI Comparison

VNRX vs DHAI Comparison

Compare VNRX & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • DHAI
  • Stock Information
  • Founded
  • VNRX N/A
  • DHAI 2007
  • Country
  • VNRX United States
  • DHAI United States
  • Employees
  • VNRX N/A
  • DHAI N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • DHAI
  • Sector
  • VNRX Health Care
  • DHAI
  • Exchange
  • VNRX Nasdaq
  • DHAI NYSE
  • Market Cap
  • VNRX 56.5M
  • DHAI 49.1M
  • IPO Year
  • VNRX N/A
  • DHAI N/A
  • Fundamental
  • Price
  • VNRX $0.55
  • DHAI $0.49
  • Analyst Decision
  • VNRX Strong Buy
  • DHAI
  • Analyst Count
  • VNRX 4
  • DHAI 0
  • Target Price
  • VNRX $4.17
  • DHAI N/A
  • AVG Volume (30 Days)
  • VNRX 103.1K
  • DHAI 310.5K
  • Earning Date
  • VNRX 03-24-2025
  • DHAI 02-14-2025
  • Dividend Yield
  • VNRX N/A
  • DHAI N/A
  • EPS Growth
  • VNRX N/A
  • DHAI N/A
  • EPS
  • VNRX N/A
  • DHAI N/A
  • Revenue
  • VNRX $1,285,827.00
  • DHAI $69,573,000.00
  • Revenue This Year
  • VNRX $71,446.31
  • DHAI N/A
  • Revenue Next Year
  • VNRX N/A
  • DHAI N/A
  • P/E Ratio
  • VNRX N/A
  • DHAI N/A
  • Revenue Growth
  • VNRX 97.50
  • DHAI 5.40
  • 52 Week Low
  • VNRX $0.43
  • DHAI $0.48
  • 52 Week High
  • VNRX $1.10
  • DHAI $3.67
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 41.65
  • DHAI 31.78
  • Support Level
  • VNRX $0.56
  • DHAI $0.48
  • Resistance Level
  • VNRX $0.61
  • DHAI $0.69
  • Average True Range (ATR)
  • VNRX 0.04
  • DHAI 0.09
  • MACD
  • VNRX -0.00
  • DHAI -0.00
  • Stochastic Oscillator
  • VNRX 2.67
  • DHAI 4.00

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About DHAI DIH HOLDINGS US INC

DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.

Share on Social Networks: